UCK2 and neoplasm: Studies have shown that in hepatocellular carcinoma, down-regulation of UCK2 induces cell cycle arrest and activates the age-related secretory phenotype associated with the TNF-α NFκB signaling pathway to alter the tumor microenvironment.